Biomind Labs Inc.
BMNDF
$0.25
-$0.18-41.79%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.38M | 811.60K | 844.40K | 356.30K | 370.20K |
| Depreciation & Amortization | 0.00 | 0.00 | 2.20K | 4.40K | 6.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.38M | 811.60K | 846.60K | 389.10K | 393.00K |
| Operating Income | -1.38M | -811.60K | -846.60K | -389.10K | -393.00K |
| Income Before Tax | -1.45M | -887.70K | -850.40K | -113.80K | -45.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.45 | -0.89 | -0.85 | -0.11 | -0.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.45M | -887.70K | -850.40K | -113.80K | -45.50K |
| EBIT | -1.38M | -811.60K | -846.60K | -389.10K | -393.00K |
| EBITDA | -1.37M | -811.10K | -844.40K | -384.70K | -386.30K |
| EPS Basic | -0.02 | -0.01 | -0.01 | 0.00 | 0.00 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 |
| EPS Diluted | -0.02 | -0.01 | -0.01 | 0.00 | 0.00 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 310.29M | 310.29M | 310.29M | 310.29M | 307.19M |
| Average Diluted Shares Outstanding | 310.29M | 310.29M | 310.29M | 310.29M | 307.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |